IE
SOPH icon

Israel Englander’s SOPHiA GENETICS SOPH Stock Holding History

Israel Englander’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799K Buy
138,409
+128,267
+1,265% +$651K ﹤0.01% 4471
2026
Q1 		$50.2K Sell
10,142
-115,316
-92% -$561K ﹤0.01% 5433
2025
Q4 		$586K Sell
125,458
-100,445
-44% -$455K ﹤0.01% 4844
2025
Q3 		$1.08M Sell
225,903
-358,520
-61% -$1.23M ﹤0.01% 4574
2025
Q2 		$1.81M Buy
584,423
+45,304
+8% +$135K ﹤0.01% 3969
2025
Q1 		$1.79M Sell
539,119
-159,515
-23% -$561K ﹤0.01% 3887
2024
Q4 		$2.18M Buy
698,634
+42,689
+7% +$145K ﹤0.01% 3571
2024
Q3 		$2.38M Sell
655,945
-6,711
-1% -$27.3K ﹤0.01% 3549
2024
Q2 		$3.03M Sell
662,656
-1,158,816
-64% -$5.65M ﹤0.01% 3169
2024
Q1 		$8.98M Sell
1,821,472
-67,130
-4% -$324K ﹤0.01% 2292
2023
Q4 		$8.9M Sell
1,888,602
-42,790
-2% -$160K ﹤0.01% 2301
2023
Q3 		$4.93M Buy
1,931,392
+314,695
+19% +$998K ﹤0.01% 2702
2023
Q2 		$7.24M Buy
1,616,697
+395,303
+32% +$1.79M ﹤0.01% 2326
2023
Q1 		$6.07M Buy
1,221,394
+956,861
+362% +$3.1M ﹤0.01% 2435
2022
Q4 		$545K Buy
264,533
+10,876
+4% +$24.4K ﹤0.01% 4684
2022
Q3 		$667K Buy
253,657
+226,519
+835% +$794K ﹤0.01% 4705
2022
Q2 		$98K Sell
27,138
-44,643
-62% -$226K ﹤0.01% 5939
2022
Q1 		$555K Sell
71,781
-48,393
-40% -$544K ﹤0.01% 5043
2021
Q4 		$1.69M Sell
120,174
-193,353
-62% -$2.85M ﹤0.01% 3924
2021
Q3 		$5.5M Buy
+313,527
New +$5.51M ﹤0.01% 2755

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Israel Englander's SOPH Position: Q2 2026 in Review

Israel Englander increased its SOPHiA GENETICS (SOPH) stake by 1,265% in Q2 2026, buying an estimated $651K and bringing the position to 138,409 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #4471.

Israel Englander first reported a position in SOPH in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.98M in Q1 2024. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Israel Englander held 138,409 shares of SOPHiA GENETICS worth $799K as of Q2 2026.
  • Israel Englander bought 128,267 SOPHiA GENETICS shares in Q2 2026, an estimated $651K.
  • SOPHiA GENETICS made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4471 holding.
  • Israel Englander first reported a position in SOPHiA GENETICS in Q3 2021 and has held it in 20 quarters since.
  • Israel Englander's SOPHiA GENETICS position peaked at $8.98M in Q1 2024.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.